- Coordinator
- Universite De Bordeaux, France
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €1.2m
- Total cost
- —
- Partners
- 14 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101086247
What the project is doing
In the project's own words, from its summary on CORDIS.
The PSYchiatric disorders and COmorbidities caused by pollution in the MEDiterranean area (PsyCoMed) project proposes a MSCA-Staff Exchange program that aims to characterise the role of anthropogenic pollutants in the Mediterranean area as a risk factor of neuropsychiatric disorders and associated pathologies, and the role of neuroinflammatory responses in the disease progression. The consortium comprises 11 beneficiaries (8 academic, 3 SMEs) and 3 TC partners putting together complementary expertises in environmental and life sciences (academics) and analytical biology or natural therapeutic phytocompounds (SMEs).
Through a multi-scale (from molecular to clinical science), multi-modal (from mechanistic to behavioural approaches), and inter-sectoral strategy, PsyCoMed will correlate the effects of pollutants on psychiatric symptoms with alterations of inflammatory pathways in animal models and psychiatric patients. We will investigate neural mechanisms underlying pathological changes in vitro and in in vivo preclinical models. Natural substances with therapeutic potential will be tested for their ability to restore healthy mechanisms and alleviate pathological symptoms in animal models.
PsyCoMed offers a unique framework to build a network synergy by bringing together themes and scientific practises in the Mediterranean area. The partners will share knowledge/know-how through secondments and workshops in support of PsyCoMed scientific objectives. This will improve the skills of staff members and their opening to the academic and private sectors. By proposing common protocols and experimental design, the participants will foster standardization of experimental procedures and diffusion of good laboratory practise.
At a global level, the consortium will acquire the capacity to tackle complex neurobiological challenges, while building long-lasting collaborations. PsyCoMed will provide decision-makers with the ground for public health orientations with societal impact.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite De Bordeaux | Bordeaux | France | Coordinator |
| The Florey Institute of Neuroscience and Mental Health | Parkville | Australia | Associatedpartner |
| Alexandria University | Alexandria | Egypt | Associatedpartner |
| Universitat Jaume I De Castellon | Castellon De La Plana | Spain | Participant |
| Benephyt | Strasbourg | France | Participant |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Watchfrog | Evry | France | Participant |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Flanat Research Italia SRL | Rho | Italy | Participant |
| Universite De Saint Esprit-Kaslik Autorite Religieuse | Jounieh | LB | Associatedpartner |
| Universite Cadi Ayyad | Marrakech | Morocco | Associatedpartner |
| Universita Ta Malta | Msida | Malta | Participant |
| Uniwersytet Jagiellonski | Krakow | Poland | Participant |
| Universite De Tunis El Manar | Tunis | Tunisia | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI